Rothschild & Co Initiates Coverage On AeroVironment with Neutral Rating, Announces Price Target of $165
Rothschild & Co initiates coverage on AeroVironment (NASDAQ:AVAV) with a Neutral rating and announces Price Target of $165.
Stocks · News reference
Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday
U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orchestra Biomed, Clover Health and AeroVironment also rose.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Pete Hegseth Taps Elon Musk, Palmer Luckey to Examine Future of Warfare From Underground to Moon: No 'Creative Limitations or Restrictions'
Hegseth has tapped Musk, Luckey and Newt Gingrich to help the Pentagon plan for future warfare driven by AI, robotics and autonomous weapons.
'Hegseth to Unveil New Pentagon Drone Group, Senator Says' - Bloomberg
Bragar Eagel & Squire, P.C. is Investigating Aerovironment, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Law firm Bragar Eagel & Squire is investigating Aerovironment Inc. on behalf of long-term stockholders following a class action complaint filed in May 2026. The lawsuit alleges that the company's board made false statements and failed to disclose material facts regarding potential competition for work related to the Satellite Communication Augmentation Resource program and U.S. Space Force satellite modernization efforts.
UPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D. to Its Board of Directors
Clover Health announced the appointments of former U.S. Senator Robert Torricelli and Dr. Brian J. Miller, M.D. to its Board of Directors, effective immediately. Senator Torricelli will serve on the Audit Committee while Dr. Miller will serve on the Clinical Committee. The appointments fill two board vacancies and bring the board to nine directors. Both appointees bring extensive experience in healthcare policy, Medicare Advantage, clinical practice, and business strategy.
8-K/A filing — CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Filed: 2026-09-25 AccNo: 0001801170-26-000232 Size: 159 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits